PE20200449A1 - COMPOUNDS, PROCEDURE FOR THE PRODUCTION OF COMPOUNDS, ENRICHED EXTRACT, ACTIVE FRACTIONS OF ENRICHED EXTRACTS, PROCEDURE FOR THE PRODUCTION OF ENRICHED EXTRACTS, METHOD FOR SELECTING PLANT BIOMASS FOR PRODUCTION, COMPOSITION AND USE OF INRICHED EXTRACTS FOR TRUNK EXTRACTS - Google Patents
COMPOUNDS, PROCEDURE FOR THE PRODUCTION OF COMPOUNDS, ENRICHED EXTRACT, ACTIVE FRACTIONS OF ENRICHED EXTRACTS, PROCEDURE FOR THE PRODUCTION OF ENRICHED EXTRACTS, METHOD FOR SELECTING PLANT BIOMASS FOR PRODUCTION, COMPOSITION AND USE OF INRICHED EXTRACTS FOR TRUNK EXTRACTSInfo
- Publication number
- PE20200449A1 PE20200449A1 PE2019001711A PE2019001711A PE20200449A1 PE 20200449 A1 PE20200449 A1 PE 20200449A1 PE 2019001711 A PE2019001711 A PE 2019001711A PE 2019001711 A PE2019001711 A PE 2019001711A PE 20200449 A1 PE20200449 A1 PE 20200449A1
- Authority
- PE
- Peru
- Prior art keywords
- extracts
- production
- compounds
- enriched
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/47—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/92—Unsaturated compounds containing keto groups containing —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Medical Informatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Abstract
Referido a compuestos que comprenden I, II y III; en donde R es H, OH, OGlyc (glicosido); R1, R1'y R1'' son H o OH; R2 es H, COOH, entre otros; R3 es H, OH, CH3, entre otros; R4, R4' son H, OH, CH2OH, entre otros; R5, R5' es H, CH3, CHO, entre otros; R6 es CHO, COOH, entre otros; R7 es H o CH3; R8, R8', R8'' son CHO, CH3, CH2OH, entre otros; y los enlaces discontinuos son enlaces simples o dobles entre carbonos, hasta dos dobles enlaces por estructura. Estos compuestos tienen actividad inmunosupresora. Estos compuestos son derivados de ipolamiida. Tambien se refiere a un procedimiento que comprende someter al menos un compuesto de ipolamiida a una etapa de calentamiento a altas temperaturas en un disolvente adecuado durante un periodo de tiempo suficiente para la produccion de dichos compuestos activos. Tambien se refiere a la produccion de un extracto enriquecido, de plantas del genero Stachytarpheta, metodo para seleccionar biomasa vegetal para produccion; y su uso en el tratamiento de pacientes con vitiligo.Referred to compounds comprising I, II and III; where R is H, OH, OGlyc (glycoside); R1, R1 'and R1' 'are H or OH; R2 is H, COOH, among others; R3 is H, OH, CH3, among others; R4, R4 'are H, OH, CH2OH, among others; R5, R5 'is H, CH3, CHO, among others; R6 is CHO, COOH, among others; R7 is H or CH3; R8, R8 ', R8 "are CHO, CH3, CH2OH, among others; and discontinuous bonds are single or double bonds between carbons, up to two double bonds per structure. These compounds have immunosuppressive activity. These compounds are derivatives of ipolamiide. It also refers to a process that comprises subjecting at least one ipolamiide compound to a heating step at high temperatures in a suitable solvent for a period of time sufficient for the production of said active compounds. It also refers to the production of an enriched extract, from plants of the genus Stachytarpheta, a method for selecting plant biomass for production; and its use in the treatment of patients with vitiligo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR102017003318-0A BR102017003318A2 (en) | 2017-02-17 | 2017-02-17 | compounds, compound production process, enriched extract, active enriched fraction fractions, enriched extract production process, plant biomass selection method for enriched extract production, composition and use for treatment of immune disorders |
| PCT/BR2018/050037 WO2018148816A2 (en) | 2017-02-17 | 2018-02-19 | Compounds, process of production of compounds, enriched extract, enriched extract active fractions, enriched extract process of production, method for selecting vegetal biomass for enriched extract production, composition and use for treatment of immunological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20200449A1 true PE20200449A1 (en) | 2020-02-28 |
Family
ID=61282932
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2019001711A PE20200449A1 (en) | 2017-02-17 | 2018-02-19 | COMPOUNDS, PROCEDURE FOR THE PRODUCTION OF COMPOUNDS, ENRICHED EXTRACT, ACTIVE FRACTIONS OF ENRICHED EXTRACTS, PROCEDURE FOR THE PRODUCTION OF ENRICHED EXTRACTS, METHOD FOR SELECTING PLANT BIOMASS FOR PRODUCTION, COMPOSITION AND USE OF INRICHED EXTRACTS FOR TRUNK EXTRACTS |
| PE2024002048A PE20242300A1 (en) | 2017-02-17 | 2018-02-19 | COMPOUNDS, COMPOUND PRODUCTION PROCEDURE, ENRICHED EXTRACT, ACTIVE FRACTIONS OF ENRICHED EXTRACTS, PROCEDURE FOR PRODUCTION OF ENRICHED EXTRACTS, METHOD FOR SELECTING PLANT BIOMASS FOR PRODUCTION, COMPOSITION AND USE OF ENRICHED EXTRACTS FOR THE TREATMENT OF IMMUNOLOGICAL DISORDERS |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2024002048A PE20242300A1 (en) | 2017-02-17 | 2018-02-19 | COMPOUNDS, COMPOUND PRODUCTION PROCEDURE, ENRICHED EXTRACT, ACTIVE FRACTIONS OF ENRICHED EXTRACTS, PROCEDURE FOR PRODUCTION OF ENRICHED EXTRACTS, METHOD FOR SELECTING PLANT BIOMASS FOR PRODUCTION, COMPOSITION AND USE OF ENRICHED EXTRACTS FOR THE TREATMENT OF IMMUNOLOGICAL DISORDERS |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20200231561A1 (en) |
| EP (2) | EP3583103B1 (en) |
| JP (2) | JP7349362B2 (en) |
| KR (2) | KR102882868B1 (en) |
| CN (1) | CN110475768B (en) |
| AU (2) | AU2018221956B2 (en) |
| BR (2) | BR102017003318A2 (en) |
| CA (2) | CA3052713A1 (en) |
| CL (1) | CL2019002309A1 (en) |
| CO (1) | CO2019008891A2 (en) |
| CY (1) | CY1125187T1 (en) |
| DK (1) | DK3583103T3 (en) |
| EC (1) | ECSP19058322A (en) |
| ES (1) | ES2909387T3 (en) |
| HR (1) | HRP20220377T1 (en) |
| IL (2) | IL268732B2 (en) |
| LT (1) | LT3583103T (en) |
| MX (2) | MX2019009655A (en) |
| NZ (1) | NZ756074A (en) |
| PE (2) | PE20200449A1 (en) |
| PL (1) | PL3583103T3 (en) |
| PT (1) | PT3583103T (en) |
| RS (1) | RS63162B1 (en) |
| SA (1) | SA519402443B1 (en) |
| SG (1) | SG11201907375VA (en) |
| SI (1) | SI3583103T1 (en) |
| SM (1) | SMT202200121T1 (en) |
| WO (1) | WO2018148816A2 (en) |
| ZA (2) | ZA201906106B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115304652A (en) * | 2022-07-25 | 2022-11-08 | 福建华闽晟业生物科技有限公司 | Method for preparing new sesamoside by using pennisetum hydridum |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3703543A (en) * | 1969-11-05 | 1972-11-21 | American Home Prod | Hydroxamic acids of alicyclic amino acids |
| ATE715T1 (en) * | 1978-06-03 | 1982-03-15 | Institut De Recherches Chimiques Et Biologiques Appliquees (I.R.C.E.B.A.) Societe A Responsabilite Limitee Dite: | MEDICINAL PRODUCTS CONTAINING A CYCLOPENTYLALDEHYDE DERIVATIVE. |
| DE3030477C2 (en) * | 1980-08-12 | 1986-10-16 | Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe | Iridoid derivatives, processes for their preparation and their use |
| JPH0366682A (en) * | 1989-08-04 | 1991-03-22 | Tsumura & Co | New ylidoid derivative |
| US5272172A (en) * | 1990-10-09 | 1993-12-21 | Tsumura & Co. | Iridoid derivatives and the use thereof as a drug |
| DE19644422C2 (en) * | 1996-10-25 | 2000-06-15 | Stefan Schulz | Use of terpenes to treat autoimmune diseases and graft rejection |
| EP1145709A1 (en) * | 2000-04-14 | 2001-10-17 | Laboratoires Serobiologiques | Use of natural products to prepare cosmetic compositions |
| AU2003224361B2 (en) * | 2002-05-10 | 2008-01-31 | Council Of Scientific And Industrial Research | Hepatoprotective activity of 2'-p-Hydroxybenzoylmussaenosidic acid |
| EP1371372A1 (en) * | 2002-06-08 | 2003-12-17 | Cognis Iberia, S.L. | Use of active substance mixtures containing tocopherols and harpagophytum procumbens extracts for the preparation of a drug against rheumatic arthritis |
| JP2008024670A (en) * | 2006-07-24 | 2008-02-07 | Daiwa Kagaku Kogyo Kk | Pest control agent |
| BRPI0719505A2 (en) * | 2006-12-21 | 2013-12-10 | Du Pont | "Hydrogenated Cattle Herb Oil Preparation Processes" |
| BRPI0700767B8 (en) * | 2007-02-15 | 2021-05-25 | Ache Laboratorios Farmaceuticos Sa | pharmaceutical composition, pharmaceutical product, process for obtaining pharmaceutical compounds and use of such compounds for the treatment of vitiligo |
| WO2013032308A2 (en) * | 2011-09-02 | 2013-03-07 | 동국대학교 산학협력단 | Novel enzymatic-type time-temperature integrator using a laccase |
| CN103120699B (en) * | 2011-11-18 | 2017-04-19 | 天津市国际生物医药联合研究院 | Application of iridoid in preparation of anti-SARS (severe acute respiratory syndromes) medicines |
| CN103690551A (en) * | 2013-07-18 | 2014-04-02 | 江苏大学 | Iridoid glycoside extracts in cleavers and extraction method and medical application thereof |
| DE102015102020A1 (en) * | 2015-02-12 | 2016-08-18 | Renate Wilmanowicz | Immunologically active phytogen mixture and its use in prevention and in a process for the treatment of efflorescences |
-
2017
- 2017-02-17 BR BR102017003318-0A patent/BR102017003318A2/en active Search and Examination
-
2018
- 2018-02-19 KR KR1020197026718A patent/KR102882868B1/en active Active
- 2018-02-19 JP JP2019544005A patent/JP7349362B2/en active Active
- 2018-02-19 EP EP18707229.3A patent/EP3583103B1/en active Active
- 2018-02-19 CA CA3052713A patent/CA3052713A1/en active Pending
- 2018-02-19 MX MX2019009655A patent/MX2019009655A/en unknown
- 2018-02-19 BR BR112019017128-2A patent/BR112019017128A2/en active Search and Examination
- 2018-02-19 HR HRP20220377TT patent/HRP20220377T1/en unknown
- 2018-02-19 WO PCT/BR2018/050037 patent/WO2018148816A2/en not_active Ceased
- 2018-02-19 EP EP21215133.6A patent/EP4001270A1/en active Pending
- 2018-02-19 AU AU2018221956A patent/AU2018221956B2/en active Active
- 2018-02-19 IL IL268732A patent/IL268732B2/en unknown
- 2018-02-19 KR KR1020257031344A patent/KR20250145126A/en active Pending
- 2018-02-19 CA CA3259255A patent/CA3259255A1/en active Pending
- 2018-02-19 SI SI201830594T patent/SI3583103T1/en unknown
- 2018-02-19 DK DK18707229.3T patent/DK3583103T3/en active
- 2018-02-19 NZ NZ756074A patent/NZ756074A/en unknown
- 2018-02-19 ES ES18707229T patent/ES2909387T3/en active Active
- 2018-02-19 SM SM20220121T patent/SMT202200121T1/en unknown
- 2018-02-19 US US16/486,683 patent/US20200231561A1/en active Pending
- 2018-02-19 PE PE2019001711A patent/PE20200449A1/en unknown
- 2018-02-19 RS RS20220241A patent/RS63162B1/en unknown
- 2018-02-19 PL PL18707229.3T patent/PL3583103T3/en unknown
- 2018-02-19 CN CN201880018995.0A patent/CN110475768B/en active Active
- 2018-02-19 IL IL313974A patent/IL313974A/en unknown
- 2018-02-19 PE PE2024002048A patent/PE20242300A1/en unknown
- 2018-02-19 LT LTEPPCT/BR2018/050037T patent/LT3583103T/en unknown
- 2018-02-19 SG SG11201907375VA patent/SG11201907375VA/en unknown
- 2018-02-19 PT PT187072293T patent/PT3583103T/en unknown
-
2019
- 2019-08-13 MX MX2022012282A patent/MX2022012282A/en unknown
- 2019-08-14 CL CL2019002309A patent/CL2019002309A1/en unknown
- 2019-08-14 EC ECSENADI201958322A patent/ECSP19058322A/en unknown
- 2019-08-15 SA SA519402443A patent/SA519402443B1/en unknown
- 2019-08-15 CO CONC2019/0008891A patent/CO2019008891A2/en unknown
- 2019-09-16 ZA ZA2019/06106A patent/ZA201906106B/en unknown
-
2022
- 2022-03-16 AU AU2022201835A patent/AU2022201835B2/en active Active
- 2022-03-21 CY CY20221100223T patent/CY1125187T1/en unknown
-
2023
- 2023-01-25 JP JP2023009384A patent/JP7685540B2/en active Active
-
2025
- 2025-02-28 ZA ZA2025/01840A patent/ZA202501840B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY37435A (en) | REPLACED PIRROLIDINS AND METHODS TO USE THEM | |
| CL2020003368A1 (en) | Composition and method of treating pain | |
| UY37564A (en) | ISOLATED FROM LYSINIBACILLUS AND USES OF THE SAME | |
| CO2018005361A2 (en) | Injectable botulinum toxin formulations and their methods of use that have long-term therapeutic or cosmetic effects | |
| CL2020000632A1 (en) | Composition and method for the treatment of autism. | |
| MX2019002750A (en) | Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer. | |
| CL2017000998A1 (en) | Composition comprising a biological control agent of the species bacillus subtilis and a fungicide of the group of inhibitors of mitosis and cell division, such as fenamidone. (divisional application 3272-2014) | |
| PE20220017A1 (en) | KCNT1 INHIBITORS AND METHODS OF USE | |
| PE20191496A1 (en) | 2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES | |
| PE20181345A1 (en) | IMIDAZO [4,5-C] QUINOLIN-2-ONA COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER | |
| CL2008000725A1 (en) | Compounds derived from aromatic heterocycles; pharmaceutical composition; farm kit; use of the composition and compounds as glucan synthase inhibitors for the treatment or prevention of the growth of fungal pathogens in plants and to treat or prevent fungal infections. | |
| MX2017001278A (en) | Plant inoculation method. | |
| CL2017000562A1 (en) | Algae concentrated extract, its method of production and use in agriculture | |
| AR107967A1 (en) | MODIFIED Hyaluronic Acid, METHOD FOR THEIR PREPARATION AND USES OF THE SAME | |
| AR115081A1 (en) | ISOLATED FROM MICROBACTERIA AND THEIR USES | |
| CO2019007409A2 (en) | Tricyclic enone pyrimidin derivatives for rorγ inhibition and other uses | |
| MX2021002215A (en) | TETRAHYDROPYRIDO-PYRIMIDINE DERIVATIVES AS AHR MODULATORS. | |
| CO2018005971A2 (en) | Composition of plant growth regulator that has synergistic effect | |
| GT201600091A (en) | DERIVATIVES OF PURINA 2, 6-SUBSTITUTES AND ITS USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS | |
| BR112016016870A2 (en) | ICARIIN DERIVATIVES, THEIR USES, AND PHARMACEUTICAL COMPOSITION | |
| SV2017005466A (en) | PIRAZOLPIRIDINAMINS AS INHIBITORS OF MKNK1 AND MKNK2 | |
| MX2022007671A (en) | Anthelmintic compounds comprising azaindoles structure. | |
| BR112021017955A2 (en) | Sunscreen for crop plants | |
| PE20181450A1 (en) | 1,3,4-THADIAZOLE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER | |
| PE20200449A1 (en) | COMPOUNDS, PROCEDURE FOR THE PRODUCTION OF COMPOUNDS, ENRICHED EXTRACT, ACTIVE FRACTIONS OF ENRICHED EXTRACTS, PROCEDURE FOR THE PRODUCTION OF ENRICHED EXTRACTS, METHOD FOR SELECTING PLANT BIOMASS FOR PRODUCTION, COMPOSITION AND USE OF INRICHED EXTRACTS FOR TRUNK EXTRACTS |